Helus Pharma Inc. (HELP) — Earnings Call Analysis & IR Page

Helus Pharma Inc is a Healthcare company operating in Biotechnology with a $642.9M market cap.

Most recent earnings call: Q2 FY26 on Nov 13, 2025.

3 earnings calls indexed on Spoken Alpha.

Behavioral analysis

Management language signature

Disclosures

Investor Relations

Confidence: 0.81

ir.helus.com

Extracted from SEC 10-K filing, 2026-10-04.

Transcripts

Recent earnings calls

Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.

All 3 calls

History

Earnings history

Reported quarters with consensus, surprise, and 1-day reaction context.

No earnings history available.

Peers

Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.

API

For developers and AI agents

The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for HELP.

$ curl https://api.spokenalpha.com/v1/companies/HELP

Get an API key API docs

FAQ

Frequently asked about HELP

Where can I find Helus Pharma Inc.'s (HELP) earnings call transcripts?

Spoken Alpha indexes HELP's earnings call transcripts at https://spokenalpha.com/companies/HELP. Each call links to attributed speakers and parsed analyst Q&A. Helus Pharma Inc.'s own investor relations page is at https://ir.helus.com/.

When was Helus Pharma Inc.'s most recent earnings call?

Helus Pharma Inc. (HELP) held its most recent earnings call on 2025-11-13, covering fiscal Q2 2026.

What sector is HELP in?

Helus Pharma Inc. (HELP) operates in the Healthcare sector (Biotechnology industry).

Overview